Sahajanand Medical Technologies, India Receives CE mark on Two Sirolimus Eluting Coronary Stents

JJune 26, 2011. Surat, India. Sahajanand Medical Technologies (SMT) announced today that it has received European CE marking for two Sirolimus eluting coronary stent systems; Supralimus® (Sirolimus eluting stents on stainless steel platform) & Supralimus-Core® (Sirolimus eluting stent on chromium cobalt platform).

Surat, gujarat, June 29, 2011 /India PRwire/ -- The CE approval for Supralimus® and Supralimus-Core® brings the company the distinction of being the first in the world to have CE approval for both Sirolimus and Paclitaxel -eluting coronary stents and in total three CE approved drug eluting stents. "The CE mark for Supralimus® and Supralimus-Core® is a significant accomplishment that substantiates our product's excellent clinical outcomes. This further confirms our commitment to providing patients and clinicians new treatment options for coronary artery disease." shared Dhirajlal Kotadia-CEO of Sahajanand, "The excellent flexibility, highly deliverable system and proven safety and efficacy of Sirolimus with the biodegradable polymers make our stents an excellent choice for a variety of patients" he added.

'The drug coating in multiple layers with the use of biodegradable layers for the Supralimus and Supralimus Core stent is designed to deliver the drug in a biphasic manner: an initial burst dose, followed by a controlled release of the drug which will likely reduce late adverse clinical events compared to stents with non-biodegradable polymer' said Dr. Atul Abhyankar, Medical Director of SMT and a renowned cardiologist. "In the early days of evolution of drug eluting stents SMT had the foresight about the safety of biodegradable polymers and was the first to pioneer the utilization of biodegradable polymer on all of its type of drug -eluting stents " he added. Dr. Pedro Lemos MD, Ph.D, from InCor Institute, University of São Paulo Medical School shared his own experience "I have been using the Supralimus stent for more than 5 years now, with an accumulated clinical experience that sums hundreds of patients. In addition, we have run a randomized trial that evaluated the short and long-term outcomes of patients treated with that stent. Both in daily practice as well as in the context of a clinical study, the Supralimus presented a very good clinical performance". SMT offers Stainless Steel and Cobalt Chromium bare metal stents, Paclitaxel eluting Stainless Steel stent and Sirolimus eluting Stainless Steel and Cobalt Chromium stents. The wide range of sizes of both Supralimus® and Supralimus-Core® from 8 mm to 40 mm with one of lowest strut thickness of CE approved chromium-cobalt and stainless steel stents.

Indications (Supralimus)

Supralimus® Sirolimus eluting coronary stent system is indicated for use in-patients with symptomatic ischemic heart disease due to coronary artery lesions with a reference vessel diameter ranging from 2.25 mm to 4.00 mm and is intended to improve coronary luminal diameter.

Indications (Supralimus-Core)

Supralimus-Core™ Sirolimus eluting coronary stent system is indicated for use in-patients with symptomatic ischemic heart disease due to coronary artery lesions with a reference vessel diameter ranging from 2.5 mm to 3.5 mm and is intended to improve coronary luminal diameter.

Notes to Editor

About Sahajanand Medical Technologies:

Established in the year 1998, SMTPL became the first Indigenous Stent Manufacturer in world to have two DES systems in its product portfolio. SMTPL is the first company to get CE approval for DES with Biodegradable Polymers. All the DESs are made with proprietary blend of Biodegradable Polymers. The company has both Stainless Steel & Cobalt Chromium platforms. It is India's largest manufacturing company based for Evidence Based Implantable Medical Devices and Medical Equipments. The products are manufactured conforming to the international quality standards and are offered at the most competitive prices. The Company is ISO 9001 and ISO 13485 certified & also obtained CE certification for its advanced range of products. This gives assurance of company's quality consciousness. For more information log on to:

Journalists and Bloggers
Visit India PRwire for Journalists for releases, photos, email alerts and customized feeds just for Media.

If you have any query regarding information in the press releases, please contact the company listed in the press release itself. Please do not call India PRwire, we will be unable to assist you with your inquiry.

Sahajanand Medical Technologies Pvt. Ltd. recent press release(s)

SMT & ST Introduce MIDAAS- a Novel IT system for Interventional Cardiologists

Surat, India- 17th May 2013- Sahajanand Medical Technologies Pvt Ltd (SMT) & Sahajanand Technologies Pvt Ltd (ST) are pleased to announce the launch of MIDAAS, an IT system for the research-oriented Interventional Cardiologists, who aim to optimize patient data management and analysis.

Catheterization and Cardiovascular Interventions (CCI) Journal Publishes Sahajanand Medical Technologies PAINT trial 1 year results

“The 74th issue of prestigious international journal Catheterization and Cardiovascular Interventions published an article of Sahajanand Medical Technologies PAINT (PercutAneous INTervention) Trial - A randomized evaluation of two drug-eluting ...

Sahajanand Medical Technologies' Sirolimus Eluting Stent Shows Excellent Outcomes

Sirolimus Eluting Stent for leading drug eluting stets developer & manufacturer Sahajanand Medical Technologies Pvt. Ltd. (SMT) displayed positive results in MAXIMUS trial that included 100 patients from the Max Heart institute in India.

Sahajanand Medical Technologies wins Golden Jubilee Award '06-07 for their "Outstanding Performance in Export Small Scale Chemical & Pharmaceuticals"

"For their outstanding performance, Sahajanand Medical Technologies has been awarded with Golden Jubilee Award '06-07 in the field of Export of Medical devices Small Scale Chemical & Pharmaceuticals. The Golden Jubilee Memorial Trust Awards are presented every year by The South Gujarat Chamber of Commerce & Industry (SGCCI) recognizing the excellence in the meritorious per...

(Sahajanand Medical Technologies) PAINT trial results support safety and efficacy of the Infinnium and Supralimus stents

Sahajanand Medical Technologies received positive results of nine month PAINT trials for Drug eluting stents, Infinnium and Supralimus. The results unveiled during plenary session of EuroPCR 2008-Barcelona.